Schrödinger Stock (NASDAQ:SDGR)
Previous Close
$15.13
52W Range
$10.95 - $23.02
50D Avg
$14.96
200D Avg
$15.36
Market Cap
$1.12B
Avg Vol (3M)
$1.35M
Beta
1.62
Div Yield
-
SDGR Company Profile
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.
SDGR Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 25 | Dec 24 | Dec 22 |
|---|---|---|---|
| Software Contribution | $15.99M | $8.02M | - |
| Maintenance | $27.29M | $23.28M | - |
| On Premise Software | $101.45M | $104.02M | - |
| Revenue From Contract With Customer Before Software Contribution | $183.51M | $172.35M | - |
| Professional Services | $9.65M | $9.80M | - |
| Software Products And Services | $199.50M | $180.37M | - |
| Hosted Software | $45.12M | $35.25M | - |
| Drug Discovery Contribution | - | - | $1.95M |
Fiscal year ends in Dec 25 | Currency in USD